A very interesting testimonial and video featuring a CHF affected person demonstrating remarkable recovery during a clinical trial using Mesoblast MPC's at a 150m dose. Unlikely to be placebo. Silviu and the entire Board will be most encouraged by this.
Its my understanding that success with CHF will give great confidence in the many other conditions that Mesoblast will be able to address.
On a relative basis it's also my understanding that CHF has been seen as the ultimate test of the functionality of our cells.
- Forums
- ASX - By Stock
- MSB
- Testimonial MPC-150-IM clinical trial phase 2
Testimonial MPC-150-IM clinical trial phase 2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.5¢ |
Change
0.015(1.53%) |
Mkt cap ! $1.150B |
Open | High | Low | Value | Volume |
99.5¢ | $1.02 | 99.0¢ | $4.221M | 4.206M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 49945 | 99.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 26060 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 24880 | 1.000 |
25 | 91629 | 0.995 |
11 | 35136 | 0.990 |
13 | 259824 | 0.985 |
12 | 612325 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.005 | 109210 | 16 |
1.010 | 209946 | 19 |
1.015 | 63117 | 13 |
1.020 | 115564 | 12 |
1.025 | 93772 | 6 |
Last trade - 15.02pm 28/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online